POZEN Inc. (POZN) Stock Analysis
DELISTED 2016
What happened to POZEN Inc. (POZN) stock?
POZEN Inc. (POZN) no longer trades on public markets. It was delisted in March 2016. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2016
- Last recorded price (historical):
- $5.94 (last quote on record before the March 2016 delisting; historical, not a current quote)
P/E 9.43 means the share price is 9.43 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
POZEN Inc. (POZN). POZEN Inc. is a pharmaceutical company focused on developing innovative treatments for pain and gastrointestinal conditions. With a strong emphasis on addressing unmet medical needs, its key product is Yosprala, aimed at reducing aspirin-associated ulcers.
Last analyzed: Jun 14, 2026POZEN Inc. (POZN) Healthcare & Pipeline Overview
More about this archive record
Can I still buy POZN shares?
No. POZN stopped trading on public markets in March 2016, so the shares are not available through a broker. Anything you see quoted for POZN elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before POZN stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to POZEN Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.